Alkaloid AD Skopje

ALK

MKALKA101011

Pharmaceuticals

End-of-day quote MACEDONIAN S.E. Other stock markets
- ^MKD	-

01-15	Alkaloid AD Skopje Reports Earnings Results for the Full Year Ended December 31, 2023	CI
2023	Alkaloid AD Skopje Reports Earnings Results for the Half Year Ended June 30, 2023	CI

Alkaloid Skopje : Other price sensitive information

April 13, 2022 at 03:06 pm

According to the Chapter 6 of the Listing Rules, we are publishing the following price sensitive information

ALKALOID AD Skopje informs that Kire Icev, Member of the Management Board of ALKALOID AD Skopje, acquired 200 ordinary shares issued by ALKALOID AD Skopje.

Attachments

Original Link
Original Document
Permalink

Disclaimer

Alkaloid AD Skopje published this content on 04 November 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 13 April 2022 14:04:06 UTC.

Latest news about Alkaloid AD Skopje

Alkaloid AD Skopje Reports Earnings Results for the Full Year Ended December 31, 2023	01-14	CI
Alkaloid AD Skopje Reports Earnings Results for the Half Year Ended June 30, 2023	26/07/23	CI
Alkaloid AD Skopje Reports Earnings Results for the First Quarter Ended March 31, 2023	14/04/23	CI
Alkaloid AD Skopje Reports Earnings Results for the Full Year Ended December 31, 2022	26/02/23	CI
Alkaloid AD Skopje Reports Earnings Results for the Full Year Ended December 31, 2021	14/01/22	CI
Alkaloid Ad Skopje Reports Earnings Results for the Half Year Ended June 30, 2021	29/07/21	CI
Alkaloid Ad Reports Earnings Results for the First Quarter Ended March 31, 2021	29/04/21	CI
Alkaloid Ad Reports Earnings Results for the Full Year Ended December 31, 2020	25/02/21	CI
Alkaloid Ad Reports Earnings Results for the Nine Months Ended September 30, 2020	14/10/20	CI
Alkaloid Ad Reports Earnings Results for the Half Year Ended June 30, 2020	30/07/20	CI
Alkaloid Ad Reports Earnings Results for the First Quarter Ended March 31, 2020	30/04/20	CI
Alkaloid AD's Equity Buyback announced on March 12, 2020, has expired.	06/04/20	CI
Alkaloid AD(MSE:ALK) commences an Equity Buyback for 10% of its issued share capital, under the authorization approved on April 8, 2019.	12/03/20	CI
Alkaloid Ad Reports Earnings Results for the Full Year Ended December 31, 2019	28/02/20	CI
Alkaloid Ad Skopje Reports Earnings Results for the Nine Months Ended September 30, 2019	30/10/19	CI
Alka-Lab announced that it has received €0.4 million in funding from Alkaloid AD	22/07/19	CI
Alkaloid Ad Reports Earnings Results for the Full Year Ended December 31, 2018	27/02/19	CI
ICC International Cannabis Corp. (CNSX:WRLD.U) acquired an unknown stake in Alkaloid AD.	23/01/19	CI
Alkaloid Ad Skopje Reports Earnings Results for the Nine Months Ended September 30, 2018	31/10/18	CI
Alkaloid Reports Consolidated Earnings Results for the First-Quarter of 2017	27/04/17	CI
Alkaloid Reports Unaudited Consolidated and Standalone Earnings Results for the Year Ended December 2016	28/02/17	CI
Alkaloid Reports Consolidated Financial Results for the First Nine Months Ended September 2016	03/11/16	CI
Alkaloid AD Reports Unaudited Consolidated Earnings Results for the First Half Ended June 2016	29/07/16	CI
Alkaloid Reports Consolidated Earnings Results for the First Quarter Ended March 2016	28/04/16	CI
Alkaloid Plans to Expand Presence in Russian Market Via Serbia	31/03/16	CI

Chart Alkaloid AD Skopje

Duration

Period

More charts

Company Profile

Alkaloid AD Skopje is a Macedonia-based company active in the pharmaceutical sector. It is engaged in the manufacturing and distribution of pharmaceuticals, the processing of herbal materials and the production of cosmetics, tea, chemical products and coating agents. It operates through two divisions: Pharmaceuticals, and Chemicals, Cosmetics and Botanicals. The Companyâs product range includes human drugs, x-ray films, haemodialysis solutions, pharmaceutical raw materials, animal health products, perfumes, household cosmetics, skin, teeth and hair care products, tea and alimentary products. It also operates a development institute for analysis, research and quality control, warehouses and laboratories. The Company operates more than 13 subsidiaries in such countries as Croatia, Serbia, Slovenia, Bosnia and Herzegovina, Bulgaria, Kosovo, the Untied States, Montenegro and the Russian Federation.

Sector

Pharmaceuticals

More about the company

Income Statement Evolution

More financial data

Sector Generic Pharmaceuticals

	1st Jan change	Capi.
ALKALOID AD SKOPJE	0.00%	0
SUN PHARMACEUTICAL INDUSTRIES LTD.	+21.98%	43.92B
OTSUKA HOLDINGS CO., LTD.	+24.56%	23.09B
SANDOZ GROUP AG	+19.36%	15.35B
CIPLA LIMITED	+14.03%	13.61B
ZYDUS LIFESCIENCES LIMITED	+46.40%	12.02B
ONO PHARMACEUTICAL CO., LTD.	-10.14%	7B
THE MEDICINES COMPANY	-0.05%	6.79B
STADA ARZNEIMITTEL	-8.87%	5.73B
ASPEN PHARMACARE HOLDINGS LIMITED	+13.07%	5.6B